Drug profile · INN
betibeglogene autotemcel
ZYNTEGLO
betibeglogene autotemcel (ZYNTEGLO) is a hemoglobin beta chain exogenous gene.
EMA: withdrawn Blood and blood forming organs (B06) B06A
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — betibeglogene autotemcel
- Class
- Blood and blood forming organs (B06)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
betibeglogene autotemcel (ZYNTEGLO) is a hemoglobin beta chain exogenous gene.
Key facts
INN betibeglogene autotemcel
Brand ZYNTEGLO
Mechanism Hemoglobin beta chain exogenous gene
Target Hemoglobin subunit beta
Therapeutic class Blood and blood forming organs (B06)
ATC code B06A
Mechanism of action
Hemoglobin beta chain exogenous gene
Primary target: Hemoglobin subunit beta
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is betibeglogene autotemcel?
betibeglogene autotemcel (ZYNTEGLO) is a hemoglobin beta chain exogenous gene.
What is the brand name for betibeglogene autotemcel?
ZYNTEGLO is a marketed brand name for betibeglogene autotemcel. Check FDA Drugs@FDA for the current US label holder and prescribing information.